Literature DB >> 8828611

Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak Collaborative Study.

J Zeman1, A Pijackova, J Behulova, O Urge, J Hyanek.   

Abstract

The intellectual development and school performance of 81 adolescents with hyperphenylalaninaemia type I between the ages 15 and 19 years were evaluated in a retrospective study. All adolescents were born between 1975-1979. In spite of the continuous changes and improvement of dietary treatment, there were no differences in the dietary approach in all phenylketonuria centres involved. A significant negative correlation between IQ of adolescents with phenylketonuria and the onset of dietary treatment was observed (r = -0.37, P < 0.01). The best school performance was found in the group of adolescents with dietary therapy which was introduced in the first weeks of life. There was no correlation between IQ of the adolescents and their phenylalanine level in the neonatal period. There was a significant negative correlation between IQ of adolescents and the average level of blood phenylalanine in the first 5 years of life (r = -0.42, P < 0.01), but this correlation was less significant later on and was not present after the age of 14 years. Dietary compliance was much more difficult to achieve in adolescence than in childhood.

Entities:  

Mesh:

Year:  1996        PMID: 8828611     DOI: 10.1007/pl00014251

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Continuation vs discontinuation of low-phenylalanine diet in PKU adolescents.

Authors:  H Schmidt; M Mahle; U Michel; J Pietz
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

2.  Intellectual and school performances in early-treated classical PKU patients. The French collaborative study.

Authors:  J M Saudubray; F Rey; H Ogier; V Abadie; J P Farriaux; J Ghisolfi; P Guibaud; J Rey; M Vidailhet
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

3.  Phenylketonuria: outcome and problems in a "diet-for-life" clinic.

Authors:  E R Naughten; B Kiely; I Saul; D Murphy
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

4.  School achievement in treated PKU children.

Authors:  K Fishler; C G Azen; E G Friedman; R Koch
Journal:  J Ment Defic Res       Date:  1989-12

5.  A treatment program for adolescents with phenylketonuria.

Authors:  L A Gleason; K Michals; R Matalon; P Langenberg; S Kamath
Journal:  Clin Pediatr (Phila)       Date:  1992-06       Impact factor: 1.168

6.  Parental problem-solving skills, stress, and dietary compliance in phenylketonuria.

Authors:  A M Fehrenbach; L Peterson
Journal:  J Consult Clin Psychol       Date:  1989-04

7.  Children with phenylketonuria: the interface of family and child functioning.

Authors:  S Shulman; R O Fisch; C E Zempel; O Gadish; P N Chang
Journal:  J Dev Behav Pediatr       Date:  1991-10       Impact factor: 2.225

8.  [Phenylketonuria: illness experience and coping mechanisms].

Authors:  J Weglage; B Fünders; A von Teeffelen-Heithoff; K Ullrich
Journal:  Z Kinder Jugendpsychiatr       Date:  1993-09

9.  [Intellectual development after relaxing the diet at the age of 5 years in typical phenylketonuria].

Authors:  V Abadie; F Rey; F Plainguet; J Rey
Journal:  Arch Fr Pediatr       Date:  1992-11

10.  Phenylketonuria diet in adolescents--energy and nutrient intake--is it adequate?

Authors:  R Link
Journal:  Postgrad Med J       Date:  1989       Impact factor: 2.401

View more
  5 in total

1.  Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia.

Authors:  L G Greeves; C C Patterson; D J Carson; R Thom; M C Wolfenden; J Zschocke; C A Graham; N C Nevin; E R Trimble
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

Review 2.  The reality of dietary compliance in the management of phenylketonuria.

Authors:  Anita MacDonald; Hulya Gokmen-Ozel; Margreet van Rijn; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2010-04-07       Impact factor: 4.982

3.  Alanine prevents the decrease of Na+,K+-ATPase activity in experimental phenylketonuria.

Authors:  A T Wyse; M E Noriler; L F Borges; P J Floriano; C G Silva; M Wajner; C M Wannmacher
Journal:  Metab Brain Dis       Date:  1999-06       Impact factor: 3.584

4.  Transition of young adults with phenylketonuria from pediatric to adult care.

Authors:  Ulrike Mütze; Annika Roth; Johannes F W Weigel; Skadi Beblo; Christoph G Baerwald; Peter Bührdel; Wieland Kiess
Journal:  J Inherit Metab Dis       Date:  2011-02-09       Impact factor: 4.982

5.  Cytoskeleton of human mononuclear cells as a possible peripheral marker for phenylalanine neurotoxicity in PKU.

Authors:  Sabrina Dick; Cláudia Funchal; Priscila de Lima Pelaez; Samanta Oliveira Loureiro; Lilian Vivian; Franciele Dall Bello Pessutto; Lúcia Maria Almeida; Clóvis Milton Duval Wannmacher; Regina Pessoa-Pureur
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.